Evidence of polyclonal hematopoiesis in a large proportion of patients with low-risk myelodysplastic syndrome.

被引：0
|
作者：
Malcovati, L
Della Porta, MG
Galli, A
Boggi, S
Malabarba, L
Pietra, D
Passamonti, F
Bergamaschi, G
Lazzarino, M
Cazzola, M
机构：
[1] Univ Pavia, Div Hematol, Sch Med, I-27100 Pavia, Italy
[2] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2364
引用
收藏
页码：649A / 650A
页数：2
相关论文
共 50 条
  • [41] A phase 2, single-arm, open-label trial to evaluate the effectiveness of darbepoetin alfa for the treatment of anemia in patients with low-risk myelodysplastic syndrome.
    Gabrilove, J
    Paquette, R
    Lyons, R
    Mushtaq, C
    Sekeres, M
    Lam, H
    Dreiling, L
    BLOOD, 2005, 106 (11) : 714A - 714A
  • [42] Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes
    Ma, Xiaomei
    Wang, Rong
    Galili, Naomi
    Mayne, Susan T.
    Wang, Sa A.
    Yu, Herbert
    Raza, Azra
    CANCER CAUSES & CONTROL, 2011, 22 (04) : 623 - 629
  • [43] Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes
    Xiaomei Ma
    Rong Wang
    Naomi Galili
    Susan T. Mayne
    Sa A. Wang
    Herbert Yu
    Azra Raza
    Cancer Causes & Control, 2011, 22 : 623 - 629
  • [44] rHuEpo treatment in low-risk myelodysplastic syndromes
    Grossi, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 574 - 574
  • [45] Supportive therapy for low-risk myelodysplastic syndromes
    Gay, Julie
    HEMATOLOGIE, 2008, 14 (03): : 178 - 184
  • [46] Amifostine in the treatment of low-risk myelodysplastic syndromes
    Grossi, A
    Fabbri, A
    Santini, V
    Leoni, F
    Nozzoli, C
    Longo, G
    Pagliai, G
    Ciolli, S
    Ferrini, PR
    HAEMATOLOGICA, 2000, 85 (04) : 367 - 371
  • [47] Erythropoietin for the anemia of low-risk myelodysplastic syndromes
    Fenaux, P
    Ades, L
    BLOOD, 2005, 106 (03) : 768 - 769
  • [48] Low-risk myelodysplastic syndromes and iron overload
    Fenaux, Pierre
    HEMATOLOGIE, 2006, 12 : 9 - 9
  • [49] Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome
    M. A. Aloe Spiriti
    R. Latagliata
    P. Niscola
    A. Cortelezzi
    M. Francesconi
    D. Ferrari
    E. Volpe
    M. Clavio
    A. Grossi
    M. Tambone Reyes
    P. Musto
    M. E. Mitra
    A. Azzarà
    D. Pagnini
    G. D’Arena
    A. Spadano
    E. Balleari
    P. Pecorari
    E. Capochiani
    E. De Biasi
    D. Perego
    B. Monarca
    F. Pisani
    G. Scaramella
    M. C. Petti
    Annals of Hematology, 2005, 84 : 167 - 176
  • [50] Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
    Wu, Yuenv
    Aanei, Carmen Mariana
    Kesr, Sanae
    Picot, Tiphanie
    Guyotat, Denis
    Catafal, Lydia Campos
    FRONTIERS IN ONCOLOGY, 2017, 7 : 164
12345